DK0760238T3 - Præparat, der kan indgives perkutant, til behandling af vandladningslidelse - Google Patents

Præparat, der kan indgives perkutant, til behandling af vandladningslidelse

Info

Publication number
DK0760238T3
DK0760238T3 DK95918735T DK95918735T DK0760238T3 DK 0760238 T3 DK0760238 T3 DK 0760238T3 DK 95918735 T DK95918735 T DK 95918735T DK 95918735 T DK95918735 T DK 95918735T DK 0760238 T3 DK0760238 T3 DK 0760238T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
urinary disorders
administered percutaneously
percutaneously
Prior art date
Application number
DK95918735T
Other languages
English (en)
Inventor
Katsuhiro Nakamura
Nobuyuki Koga
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of DK0760238T3 publication Critical patent/DK0760238T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95918735T 1994-05-18 1995-05-18 Præparat, der kan indgives perkutant, til behandling af vandladningslidelse DK0760238T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12816294 1994-05-18
PCT/JP1995/000946 WO1995031190A1 (fr) 1994-05-18 1995-05-18 Preparation administrable par voie percutanee pour le traitement des troubles de la miction

Publications (1)

Publication Number Publication Date
DK0760238T3 true DK0760238T3 (da) 2002-07-22

Family

ID=14977927

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918735T DK0760238T3 (da) 1994-05-18 1995-05-18 Præparat, der kan indgives perkutant, til behandling af vandladningslidelse

Country Status (8)

Country Link
US (1) US5770221A (da)
EP (1) EP0760238B1 (da)
KR (1) KR970703137A (da)
AU (1) AU2454495A (da)
DE (1) DE69526437T2 (da)
DK (1) DK0760238T3 (da)
ES (1) ES2172584T3 (da)
WO (1) WO1995031190A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4073517B2 (ja) * 1997-04-07 2008-04-09 久光製薬株式会社 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤
CA2336682C (en) * 1998-07-07 2006-10-10 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
AU2940000A (en) * 1999-03-11 2000-09-28 Mitsubishi Chemical Corporation Drug composition for percutaneous absorption
WO2000064434A1 (fr) * 1999-04-26 2000-11-02 Lead Chemical Co., Ltd. Preparations percutanees contenant de l'oxybutynine
AU5245600A (en) * 1999-08-09 2001-03-05 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions for treating lower uropathy
AU7703700A (en) * 1999-09-22 2001-04-24 Merck & Co., Inc. Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
ATE353636T1 (de) * 1999-12-15 2007-03-15 Hisamitsu Pharmaceutical Co Adhäsive zubereitungen
ATE517614T1 (de) 2000-04-18 2011-08-15 Hisamitsu Pharmaceutical Co Pflaster enthaltend einen anti-inflammatorischen wirkstoff
US6914169B1 (en) * 2000-05-19 2005-07-05 Hisamitsu Pharmaceutical., Inc. Patch agent
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
KR20050037405A (ko) * 2001-10-17 2005-04-21 히사미쯔 제약 주식회사 경피 흡수형 제제
JP4354678B2 (ja) 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20060188554A1 (en) * 2003-08-04 2006-08-24 Katashi Nakashima Transdermal absorption preparation
JP4593471B2 (ja) * 2003-10-20 2010-12-08 久光製薬株式会社 皮膚外用貼付剤
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
DE102004009903A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
JP5208348B2 (ja) * 2004-05-13 2013-06-12 旭化成ファーマ株式会社 ナフトピジルを含有する医薬
KR20130069764A (ko) * 2005-02-03 2013-06-26 교린 세이야꾸 가부시키 가이샤 경피 흡수형 제제
KR20080000647A (ko) * 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
JP4913738B2 (ja) * 2005-08-19 2012-04-11 ダイヤ製薬株式会社 プラスターの製造方法及びその製造装置及びプラスター用ライナー
EP2005952A1 (en) 2006-04-11 2008-12-24 Nichiban Company Limited Tamsulosin-containing percutaneous absorption type preparation
US20100092544A1 (en) * 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
JPWO2013081014A1 (ja) * 2011-11-28 2015-04-27 株式会社 ケイ・エム トランスダーム 貼付剤
WO2016088898A1 (ja) * 2014-12-05 2016-06-09 株式会社 ケイ・エム トランスダーム 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤
US11186564B2 (en) * 2016-08-04 2021-11-30 Sunovion Pharmaceuticals Inc. Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
JPS6145052A (ja) * 1984-08-07 1986-03-04 有限会社　▲カゲ▼山商事 桟瓦
EP0204968B1 (de) * 1985-05-24 1989-09-27 Beiersdorf Aktiengesellschaft Nitro-Pflaster
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4793337A (en) * 1986-11-17 1988-12-27 E. R. Squibb & Sons, Inc. Adhesive structure and products including same
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3136413B2 (ja) * 1991-02-22 2001-02-19 リードケミカル株式会社 経皮吸収型頻尿・尿失禁治療剤
JPH04273818A (ja) * 1991-02-28 1992-09-30 Kissei Pharmaceut Co Ltd 経皮投与製剤
ZA933349B (en) * 1992-05-13 1994-06-15 Alza Corp Transdermal administration of oxybutynin
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents

Also Published As

Publication number Publication date
EP0760238B1 (en) 2002-04-17
KR970703137A (ko) 1997-07-03
EP0760238A1 (en) 1997-03-05
US5770221A (en) 1998-06-23
WO1995031190A1 (fr) 1995-11-23
AU2454495A (en) 1995-12-05
EP0760238A4 (en) 1998-06-03
DE69526437D1 (de) 2002-05-23
DE69526437T2 (de) 2002-10-31
ES2172584T3 (es) 2002-10-01

Similar Documents

Publication Publication Date Title
DK0760238T3 (da) Præparat, der kan indgives perkutant, til behandling af vandladningslidelse
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
NO20020133D0 (no) Preparat for behandling av utvortes sekresjonsforstyrrelser
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DK1352896T3 (da) Adamantanderivater til behandling af inflammations-, immun- og hjertekarsygdomme
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
HU9601854D0 (en) Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1339406T3 (da) Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK0983084T3 (da) Anvendelse af hyaluronidase til fremstilling af et öjenpræparat til flydendegörelse af glaslegemet i behandlingen af öjenlidelser
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum